Evaluation of mediVR-KAGURA Guided Therapy

Status Completed

Clinical Trial Summary

The objective is to evaluate mediVR-KAGURA guided therapy for the treatments of physical and cognitive dysfunctions regardless of baseline disease in a prospective interventional design.

Clinical Trial Description

The patients sit on an upright chair, wear a head-mounted display (HMD) and grab two handheld controllers in a motion-tracked three-dimensional space called "room scale" of the mediVR-KAGURA (mediVR, Inc. Toyonaka City, Osaka, Japan). mediVR-KAGURA can provide users with >90 frames per second (fps) graphic operation with an approximately 110° viewing angle and accurate three-dimensional tracking technology. First, we evaluate conventional and maximum reaching distances at 0°, 45°, and 90° level surface for the left hand (0L, 45L, 90L) and at 90°, 135°, and 180° level surface for the right hand (90R, 135R, or 180R) for calibration in a sitting position. During rehabilitation, patients are instructed to touch a fixed objects or catch a falling objects at the pre-specified height and distance levels in each degree. Horizontal distances were classified into three categories, namely long, middle, and short which were calculated using the following formulas: 0.9 * maximum reaching distance, 0.9 * (conventional + maximum reaching distances)/2, and conventional reaching distance respectively. A falling object disappeared at a 20 cm height for safety if the patients missed to catch it. The purpose of reaching hands was to stimulate and break down body trunk balance, and to train participants to balance for stable walking. By thinking about the timing and distance and recognizing the next targets repeatedly, cognitive function was simultaneously stimulated for dual-task training. The 7 parameters of the rehabilitation programs can be set like as follows: (1) distance (short, middle or long), (2) direction (0L, 45L, 90L, 90R, 135R, or 180R), (3) height of object, (4) size of object (center or outline), (5) size of sensing sphere of the controller, (6) falling speed of the square box (from 0 to 300 cm/s), and (7) intervals for each task. Participants first underwent practical programs to familiarize themselves with mediVR-KAGURA guided rehabilitation, followed by rehabilitation programs. Provision of the rehabilitation programs will be personalized. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04562662
Study type	Interventional
Source	Japan Society of Clinical Research
Contact
Status	Completed
Phase	N/A
Start date	September 1, 2020
Completion date	March 31, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05273125` - MOBility Disorders Assessment in Patients With Mild COGnitive Disorders
Active, not recruiting	`NCT04049695` - Improving Cognition After Cancer	N/A
Completed	`NCT05912374` - Adapting a Behavioral Intervention to Accommodate Cognitive Dysfunction in People Who Inject Drugs	N/A
Recruiting	`NCT03977350` - Association Between qEEG Measure and Post-Operative Cognitive Dysfunction (POCD) and Postoperative Delirium (POD)
Not yet recruiting	`NCT06027632` - Remotely Supervised Computerized Cognitive Stimulation to Reduce Post-chemotherapy Cognitive Difficulties in Patients Treated for Localized Breast Cancer	N/A
Terminated	`NCT00754052` - Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17	Phase 3
Terminated	`NCT00754013` - Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 6 To 10	Phase 3
Completed	`NCT00719628` - Depth of Anaesthesia and Cognitive Dysfunction	N/A
Recruiting	`NCT05014399` - Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy
Completed	`NCT04966455` - Effect of Raisins on Cognitive Function in Healthy Older Adults	Phase 3
Recruiting	`NCT05372159` - Vanderbilt Memory and Aging Project
Completed	`NCT03243279` - BRS and Outcomes in Cardiothoracic Surgery
Completed	`NCT04093882` - The Relevance of the Blood-brain Barrier to Cognitive Dysfunction and Alzheimer's Disease
Recruiting	`NCT05732285` - A Pilot Randomized Controlled Trial: CoINTEGRATE	N/A
Completed	`NCT06059768` - Urdu Translation and Psychometric Analysis of Lawton IADLS.
Completed	`NCT04624529` - Validity and Reliability of a Self-evaluation Tool for Cognitive Deficits in the Acute Stage After Stroke
Not yet recruiting	`NCT04079075` - Multiple Interventions to Prevent Cognitive Decline	N/A
Active, not recruiting	`NCT04638101` - Building the Path to Resilience in Preterm Infants: Mindfulness-based Intervention	N/A
Active, not recruiting	`NCT04556305` - Lifestyle Physical Activity and Cognitive Training Interventions	N/A
Completed	`NCT03933475` - Telerehabilitation for Cognitive Impairment Following Acquired Brain Injury	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.